Trials / Unknown
UnknownNCT05725382
Nociception Level-guided Remifentanil Dosing in Children During General Anesthesia
Can Nociception Level-guided Remifentanil Dosing Reduce Postoperative Pain in Children During General Anesthesia: A Blinded, Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 264 (estimated)
- Sponsor
- Pia Jaeger, MD, PhD · Academic / Other
- Sex
- All
- Age
- 3 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to investigate whether administration of a short-acting opioid (remifentanil) guided by a pain monitor (nociceptive level monitor) during anesthesia, can reduce pain in children after surgery. The investigators hypothesize that pain monitor-guided administration of remifentanil can reduce pain postoperatively compared with standard care.
Detailed description
NOL-guided analgesia has not previously been assessed in children, and it is unknown whether this additional monitoring has any clinical benefits in a pediatric population. In the present study the investigators aim to investigate whether administration of perioperative remifentanil guided by the CE-certified Pain Monitoring Device monitor-PMD200™, also called NOL-monitor, can reduce pain (primary endpoint), opioid consumption and agitation in children aged 3-16 years undergoing surgery with intravenous anesthesia. The investigators hypothesize that NOL-guided perioperative remifentanil administration can reduce postoperative pain compared with standard clinical care (remifentanil dosing based on hemodynamic variables). All patients will receive standard analgesia and antiemetic administered perioperatively: * IV paracetamol 15 mg/kg * IV Ibuprofen 10 mg/kg, unless contraindicated * IV Morphine 25-100 μg/kg according to the extent of surgery and the departments' standard, administered 30 minutes before end of surgery (will not be included in the total perioperative or postoperative opioid consumption) * In case of minor surgery, 1-2 μg/kg fentanyl, according to the department's standard, may be administered instead of morphine at the discretion of the anesthetist (will not be included in the total perioperative or postoperative opioid consumption) * Regional anesthesia may be provided at the discretion of the anesthetist * IV ondansetron 100 μg/kg
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The NOL monitor (Pain Monitoring Device monitor-PMD200™) | NOL-guided perioperative remifentanil administration |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-10-30
- Completion
- 2025-11-01
- First posted
- 2023-02-13
- Last updated
- 2023-08-24
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05725382. Inclusion in this directory is not an endorsement.